Ajinomoto Bio Pharma Services

77 articles about Ajinomoto Bio Pharma Services

• Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

  11/28/2018

  Ajinomoto Bio-Pharma Services presented data at the World ADC Summit in San Diego this month describing a proprietary site-selective bioconjugation technology, AJICAP™.

• Ajinomoto Althea, Inc. Celebrates 20 years in San Diego and the Opening of New Facility

  8/27/2018

  Ajinomoto Althea, Inc. celebrated its 20th year in operation, making it one of the true anchors of the San Diego life science community.

• Ajinomoto Althea, Inc. Announces Additions to Management Team as it transforms into a global CDMO

  5/31/2018

  Ajinomoto Althea, Inc. announced that Bert Barbosa and Darwin Richardson, MBA, have joined Althea as Vice President of Drug Product Manufacturing and Vice President of Compliance, respectively.

• Ajinomoto Althea Inc. Opens Manufacturing Suites In New High Potency And Antibody Drug Conjugate Commercial Facility

  9/19/2017

• Ajinomoto Althea Inc. Announces New Aseptic Fill Finish Line

  8/24/2017

• Ajinomoto Althea Inc. CEO David Enloe Awarded "Most Admired CEO"

  7/6/2017

• Biologics Candidate Manufactured Using Ajinomoto Althea Inc.'s CORYNEX Protein Expression System Enters Clinical Trials For The First Time

  10/4/2016

• Ajinomoto Althea Inc. Announces Issuance Of New US Patent For Manufacturing Of Crystal Monoclonal Antibodies

  5/17/2016

• Ajinomoto Althea Inc. Expands Its Capacity Of Fill Finish Manufacturing With Addition Of Second Shift

  3/15/2016

• Ajinomoto Althea Inc. Launches Process And Analytical Development Services For Antibody Drug Conjugates (ADCs) Therapeutics

  12/10/2015

• Ajinomoto Althea Inc. Receives European GMP Certification For Commercial Aseptic Filling And Testing

  6/16/2015

• Ajinomoto Completes Acquisition of Althea Technologies, Inc.

  4/5/2013

• Ajinomoto Agrees to Acquire Althea Technologies, Inc. for $175 Million

  3/6/2013

• Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production

  2/26/2013

• Pfenex Inc. Awards Althea Technologies, Inc. a Contract for cGMP Manufacturing of Circumsporozoite Protein From Plasmodium Falciparum, a Key Malaria Antigen

  10/24/2012

• Althea Technologies, Inc. Announces Expanded Roles for Key Executives

  9/24/2012

• Althea Technologies, Inc. Appoints Dr. Dennis Fenton as Chairman of Its Scientific Advisory Board

  6/19/2012

• Althea Technologies, Inc. Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing

  5/2/2012

• Allena Pharmaceuticals, Inc. Licenses Worldwide Rights to Hyperoxaluria Portfolio from Althea Technologies, Inc.

  3/28/2012

• Althea Technologies, Inc. Appoints Martha J. Demski as Senior Vice President and Chief Financial Officer

  9/8/2011